First and second generation antipsychotics in early psychosis – no differences in efficacy or discontinuation rates « NPCi blog

This meta-analysis found no significant differences between first generation (typical) antipsychotics (FGAs) and second generation (atypical) antipsychotics (SGAs) with regard to their effects on symptoms or discontinuation rates, when used to treat early psychosis. Patients taking SGAs gained more weight than those taking FGAs, whereas FGAs were associated with more extrapyramidal side effects than SGAs.

via npci.org.uk

Posted via email from Jack's posterous